# A Study of Continuous Heart Rate Monitoring in Healthy Participants

> **NCT04682184** · NA · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Propranolol
- **DRUG:** Pseudoephedrine
- **DEVICE:** Wearable Biosensor Patch Device

## Key facts

- **NCT ID:** NCT04682184
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-27
- **Primary completion:** 2021-03-25
- **Final completion:** 2021-03-25
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04682184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04682184, "A Study of Continuous Heart Rate Monitoring in Healthy Participants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04682184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*